- Home
- WLY vs BHC Comparison
WLY vs BHC Comparison
Compare WLY & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLY
- BHC
- Stock Information
- Founded
- WLY 1807
- BHC N/A
- Country
- WLY United States
- BHC Canada
- Employees
- WLY N/A
- BHC N/A
- Industry
- WLY Books
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- WLY Consumer Discretionary
- BHC Health Care
- Exchange
- WLY Nasdaq
- BHC Nasdaq
- Market Cap
- WLY 2.1B
- BHC 1.7B
- IPO Year
- WLY N/A
- BHC N/A
- Fundamental
- Price
- WLY $43.38
- BHC $6.18
- Analyst Decision
- WLY
- BHC Hold
- Analyst Count
- WLY 0
- BHC 5
- Target Price
- WLY N/A
- BHC $7.20
- AVG Volume (30 Days)
- WLY 511.0K
- BHC 2.5M
- Earning Date
- WLY 06-17-2025
- BHC 07-31-2025
- Dividend Yield
- WLY 3.25%
- BHC N/A
- EPS Growth
- WLY N/A
- BHC N/A
- EPS
- WLY 1.53
- BHC N/A
- Revenue
- WLY $1,677,609,000.00
- BHC $9,731,000,000.00
- Revenue This Year
- WLY N/A
- BHC $3.71
- Revenue Next Year
- WLY $1.13
- BHC $5.03
- P/E Ratio
- WLY $28.35
- BHC N/A
- Revenue Growth
- WLY N/A
- BHC 8.53
- 52 Week Low
- WLY $36.50
- BHC $3.96
- 52 Week High
- WLY $53.96
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- WLY 63.99
- BHC 73.53
- Support Level
- WLY $36.50
- BHC $4.41
- Resistance Level
- WLY $39.87
- BHC $6.31
- Average True Range (ATR)
- WLY 1.23
- BHC 0.27
- MACD
- WLY 0.60
- BHC 0.17
- Stochastic Oscillator
- WLY 89.35
- BHC 92.89
About WLY John Wiley & Sons Inc.
John Wiley & Sons Inc is one of the world's greatest publishers and a trusted leader in research and learning. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.